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Endoplasmic reticulum (ER) stress refers to physiological
or pathological states that result in accumulation of
misfolded proteins in the ER. To handle misfolded proteins,
the ER has in place quality control mechanisms, including the
unfolded protein response and ER-associated degradation
(ERAD). ER stress in renal pathophysiology is a relatively
new area of research. Mice heterozygous for a mutation
in the ER chaperone, BiP, develop glomerulosclerosis and
tubulointerstitial disease. Induction of ER stress in
glomerular cells has been described in experimental models
of membranous nephropathy and membranoproliferative
glomerulonephritis, and exogenous induction of ER stress
(‘preconditioning’) reduced proteinuria. In human kidney
biopsies, markers of ER stress in glomeruli have been
identified in various noninflammatory and inflammatory
glomerulopathies. A tubulointerstitial ER stress response, in
some cases associated with tubular cell apoptosis, may occur
in glomerular diseases associated with proteinuria, including
puromycin aminonucleoside nephrosis, protein overload, and
experimental and human diabetic nephropathy. Certain
missense mutations in nephrin and podocin, as well as
underglycosylation of nephrin, result in misfolding and
retention in the ER, and eventually ERAD. Understanding the
various aspects of ER stress will provide an opportunity for
development of novel therapeutic strategies for proteinuric
diseases.
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The endoplasmic reticulum (ER) is a membranous network
that extends throughout the cytoplasm of a cell, and is
contiguous with the nuclear envelope. The ER serves as a site
for the folding, assembly, and degradation of proteins, as well
as for synthesis of steroids, cholesterol, and other lipids. In
addition, the ER is a major intracellular storage site for
calcium. Secretory, lumenal, and membrane proteins are
translocated into the lumen of the ER shortly after initiation
of synthesis (Figure 1).1 These proteins are covalently
modified and attain their correctly folded conformation in
the ER through ER-resident enzymes and chaperones. Protein
folding is catalyzed by peptidyl prolyl isomerases, whereas
glycosylation involves glycosidases and mannosidases. Fold-
ing-competent states are maintained by classical chaperones,
for example, the glucose-regulated proteins (GRP)94 and BiP
(GRP78), and lectin-like chaperones, for example, calnexin
and calreticulin. ER stress refers to physiological or
pathological states, which may increase the demand for
protein folding, or disrupt the processes by which proteins
fold, resulting in an accumulation of misfolded proteins in
the ER lumen. To rescue misfolded proteins, the ER has in
place quality control mechanism, including the unfolded
protein response (UPR)1–5 and ER-associated degradation
(ERAD).1,6–8
UPR
The UPR is a coordinated stress response that upregulates the
capacity of the ER to process abnormal proteins (Figure 1).2–4
The major UPR signaling pathways are initiated by three
protein sensors, activating transcription factor-6 (ATF6),
inositol requiring-1a (IRE1), and PERK (PKR-like ER
kinase). In resting cells, the three sensors are in an inactive
state, by association with the ER chaperone, BiP. Upon
accumulation of misfolded proteins in the ER, or depletion of
ER calcium stores, ATF6 is released from BiP and moves to
the Golgi, where it is cleaved by site-1 and site-2 proteases.
The cleaved cytosolic fragment, which has a DNA-binding
domain (containing the basic leucine zipper motif and a
transcriptional activation domain), migrates to the nucleus
to activate transcription of ER chaperones and enzymes that
promote protein folding, maturation, secretion, and ERAD.
In parallel with ATF6, IRE1 autophosphorylates and activates
its endoribonuclease activity, cleaving X-box-binding
protein-1 (XBP1) mRNA and changing the reading frame
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to yield a potent transcriptional activator. XBP1 functions in
parallel with ATF6 to activate transcription of the aforemen-
tioned genes. A third aspect of the UPR involves PERK,
which is activated through homodimerization and trans-
phosphorylation, allowing PERK to phosphorylate the
eukaryotic translation initiation factor-2a subunit (eIF2a).
This process reduces initiation AUG codon recognition; thus,
the general rate of translation is reduced, which aims at
decreasing the protein load on a damaged ER. However,
selective mRNAs, typically those that contain short open
reading frames in the 50-untranslated region, can be
preferentially translated under these conditions. Such
mRNAs include ATF4, a transcription factor that can induce
expression of UPR target genes. Although BiP may serve as a
master regulator of the UPR sensors (ATF6, IRE1, and
PERK), more recent studies suggest that IRE1 (and possibly
PERK) may bind misfolded proteins directly.4 Such direct
recognition may allow for a more nuanced set of responses.
QUALITY CONTROL AND ERAD
Calnexin and calreticulin are ER chaperones involved in the
folding of glycoproteins.1,7 ER quality control is mediated
through recognition of glycan moieties bound to proteins.
Unfolded or misfolded proteins are reglucosylated by UDP-
glucose:glycoprotein glucosyltransferase (UGGT), and ER
mannosidases affect retention time of misfolded proteins
with ER chaperones (Figure 1). Calnexin, UGGT, and
mannosidases allow misfolded proteins multiple chances to
acquire a correctly folded conformation (calnexin chaperone
cycle). However, prolonged retention of misfolded proteins
leads to ERAD.6,8 Mannose trimming of N-linked glycan has
an important role in ERAD. ER degradation-enhancing
a-mannosidase-like protein (EDEM) functions as the man-
nose8-binding lectin in the ERAD pathway, and is a key
molecule that recognizes misfolded glycoproteins. EDEM
helps misfolded proteins leave the calnexin cycle toward
degradation. The misfolded proteins are retrotranslocated
into the cytosol, where they undergo ubiquitination, a
covalent modification that marks the protein for destruction
by the proteasome. ER stress may upregulate some of the
proteins involved in ERAD, for example, EDEM, which lies
downstream of IRE1. The UPR and ERAD are intimately
linked; thus, UPR induction may increase ERAD capacity,
and loss of ERAD may lead to UPR induction.
CONSEQUENCES OF THE UPR
Activation of the UPR appears to be a generalized process
occurring in many cell types. In certain cell types, the UPR
may be important for normal physiological function,
including those cells with a high rate of protein synthesis
or whose primary function is the production of secretory- or
membrane-resident proteins. Examples include pancreatic-b
cells, which require the PERK/eIF2a pathway for main-
tenance of function and prevention of cell failure, and plasma
cells, where the IRE1/XBP1 pathway is necessary for the
production of antibodies.2 As discussed above, induction of
the UPR allows cells to recover from stress, and once
activated, the UPR may be protective to additional insults.3,4
In contrast, substantial/prolonged ER stress may be cytotoxic,
and lead to apoptosis (Figure 1).3,4,9 The proapoptotic
effector pathways may include the ATF4-mediated induction
of C/EBP homologous protein-10 (CHOP/GADD153), a
gene transcribed preferentially after eIF2a is phosphorylated
by PERK, and the activation of caspase-12, or activation of
apoptosis signal-regulating kinase-1 and c-Jun N-terminal
kinase, downstream of IRE1 (Figure 1).
ER STRESS IN RENAL PATHOPHYSIOLOGY
The role of ER stress in renal pathophysiology is a relatively
new area of research. A few comprehensive reviews on
this subject have appeared recently.10–13 The present review
highlights ER stress in conditions primarily involving the
glomerulus, focusing on glomerular pathophysiology


















































Figure 1 |Protein folding, quality control, and signaling in the
endoplasmic reticulum (ER). Solid arrow indicates enzymatic
catalysis, dotted arrow indicates an interaction, dashed arrow
indicates transport. ATF4, activating transcription factor-4; ATF6,
activating transcription factor-6; eIF2a, eukaryotic translation
initiation factor-2a subunit; EDEM, endoplasmic reticulum
degradation-enhancing a-mannosidase-like protein; ERAD,
endoplasmic reticulum-associated degradation; GRP94, glucose-
regulated protein 94; IRE1, inositol requiring-1a; JNK, c-Jun
N-terminal kinase; PERK, PKR-like ER kinase; UGGT, UDP-
glucose:glycoprotein glucosyltransferase; UPR, unfolded protein
response; XBP1, X-box-binding protein-1. Adapted from
Chevet et al.1
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NORMAL KIDNEY DEVELOPMENT AND AGING
Several ER chaperones, including BiP and GRP94, are
expressed constitutively (in the absence of ER stress), and it
is likely that these chaperones are involved in normal protein
folding and maturation during development and home-
ostasis.14 The understanding of the role of these proteins in
normal glomerular development and function is limited.
Kimura et al.15 produced a knock-in mouse expressing a
mutant BiP, which lacks the ER retention sequence. Homo-
zygous BiP mutant mice suffered from ER stress and died
shortly after birth, although the neonatal kidneys appeared
normal. In heterozygous mice, there was an increase in tubular
atrophy, dilatation, and interstitial fibrosis, as well as
glomerulosclerosis at an advanced age (80 weeks). These results
suggest that although BiP is not essential for normal kidney
development, BiP may be required for maintenance of normal
glomerular and tubular architecture.
ER STRESS IN COMPLEMENT C5b-9-MEDIATED GLOMERULAR
EPITHELIAL CELL INJURY
Among the first demonstrations of ER stress in glomerular
disease are studies on the passive Heymann nephritis (PHN)
model of experimental membranous nephropathy.16,17 In
PHN, C5b-9 assembles in glomerular epithelial cell (GEC)/
podocyte plasma membranes, ‘activates’ GECs, and leads to
proteinuria and sublytic GEC injury.18 On the basis of the
studies in GEC culture and in vivo, C5b-9 assembly induces
activation of phospholipases and protein kinases, a decline in
cellular adenosine triphosphate, production of reactive
oxygen species, and alterations in nephrin expression or
function, thereby inducing a permselectivity defect in the
glomerular capillary wall. In addition, complement attack
may activate pathways that restrict injury or facilitate
recovery. Incubation of cultured GECs with sublytic comple-
ment induced leakage of BiP and GRP94 from the ER into the
cytosol, and this leakage was enhanced by the activation of
cytosolic phospholipase A2-a (cPLA2). This effect of cPLA2 is
in keeping with the observation that activation of cPLA2
leads to phospholipid hydrolysis at the membrane of the ER.
In parallel, complement increased expression of BiP and
GRP94, activation of PERK, phosphorylation of eIF2a, and a
reduction in protein synthesis, in a cPLA2-dependent
manner. Complement-induced GEC injury was greater in
GECs transfected with BiP antisense mRNA, indicating that
induction of BiP has a functionally important role in limiting
injury. Moreover, fibroblasts from PERK-knockout mice were
more susceptible to complement-mediated injury, as com-
pared with wild-type fibroblasts. Thus, induction of ER stress
proteins represents a mechanism for protection of cells from
sustained complement attack.
Glomerular BiP and GRP94 proteins were upregulated,
and phosphorylation of eIF2a was enhanced in proteinuric
rats with PHN, compared with normal rats (Figure 2a).
Glomeruli of rats that had been injected with a subnephrito-
genic dose of adriamycin or tunicamycin (i.e., doses that did
not induce proteinuria) showed increases in GRP94 and BiP
expression. On the basis of these results, rats were treated
with subnephritogenic doses of adriamycin or tunicamycin,
and PHN was then induced in both pretreated and untreated
rats. Substantial proteinuria developed in untreated rats with
PHN, whereas proteinuria was attenuated in the rats that had
been pretreated (Figure 2b). Thus, ‘preconditioning’ to
increase ER stress can reduce C5b-9-mediated GEC injury
in vivo (Figure 2c).
ER STRESS IN OTHER EXPERIMENTAL MODELS OF
PODOCYTE INJURY
An increase in the expression of ER stress proteins occured
after incubation of cultured GECs with various compounds/


































Figure 2 | Endoplasmic reticulum (ER) stress in experimental
membranous nephropathy (passive Heymann nephritis; PHN).
(a) ER stress is increased in C5b-9-mediated podocyte injury.
Glomeruli were isolated from normal rats (control) and from rats
with PHN on day 14, and lysates were immunoblotted with
antibodies to BiP, GRP94, or phospho-eIF2a. (b) Preconditioning
of rats with a subnephritogenic dose of adriamycin (Adr) or
tunicamycin (Tun) reduces proteinuria in PHN. Rats were
untreated (Untr), or were injected with adriamycin or tunicamycin
to upregulate ER stress proteins. Four days later, rats were
injected with nephritogenic antibody to induce PHN (day 0). Urine
protein excretion was measured on days 0, 7, 9, and 13.
(c) Scheme illustrating the effect of ER stress preconditioning on
glomerular injury (proteinuria). UPR, unfolded protein response.
Panels a and b are from Cybulsky et al.,16,17 with permission.
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calcium ionophores, S-nitroso-N-acetylpenicillamine (nitric
oxide donor), and in vitro ischemia reperfusion.17,19 In vivo,
puromycin aminonucleoside nephrosis (PAN) is an experimental
rat model of minimal change disease and focal segmental
glomerulosclerosis (FSGS), and is characterized by proteinuria
and podocyte foot process effacement. In PAN, upregulation of
BiP in podocytes was evident at days 4–5, coinciding with the
development of proteinuria.17,20
A transgenic rat that overexpresses megsin, a member of
the serine protease inhibitor (serpin) superfamily, shows
accumulation of megsin in the ER of podocytes.21 In these
rats, there was marked upregulation of ER chaperones in
podocytes. ER stress in podocytes was associated with cellular
injury, as demonstrated by a reduction in synaptopodin and
an increase in desmin immunofluorescence staining.19 In
contrast, podocytes of transgenic rats overexpressing a
mutant megsin, without the capacity for polymerization
within the ER, did not exhibit ER stress or podocyte damage,
suggesting a pathogenic role for ER retention of polymerized
megsin. Presumably, increases in ER chaperones in PAN and
the megsin rat fulfill a cytoprotective role, but this has not
been examined directly.
Mutations in the cytoskeletal protein, a-actinin-4, lead to
a familial form of FSGS. Mice that develop FSGS due to
expression of an a-actinin-4 K256E transgene in podocytes
demonstrated glomerular ER stress, including upregulation
of ER chaperones, phosphorylation of eIF2a, and induc-
tion of the proapoptotic protein, CHOP.22 Expression of
a-actinin-4 K256E in cultured cells enhanced ER stress and
apoptosis. ER stress was associated with aggregation and
ubiquitination of a-actinin-4 K256E, and ‘choking’ of the
ubiquitin-proteasome system.3 This may be an example
where impairment of the proteasome results in ER stress,
possibly by an induced defect in ERAD.
ER STRESS IN PROLIFERATIVE GLOMERULONEPHRITIS
Inagi et al.23 reported on the induction of ER stress in a
model of mesangial injury. The authors showed upregulation
of the ER chaperones, BiP and ORP150, activation of PERK,
and phosphorylation of eIF2a in glomeruli of rats with anti-
Thy1 nephritis on day 7 after induction of nephritis, which
corresponds to the stage of mesangial hypercellularity.
Tunicamycin or thapsigargin given to rats 4 days before
induction of anti-Thy1 nephritis did not affect renal
pathology or function, although the compounds increased
expression of BiP and ORP150. After induction of nephritis
(day 3), in the rats preconditioned with tunicamycin or
thapsigargin, glomeruli displaying microaneurysms were
markedly reduced compared with nonpretreated rats. More-
over, subsequent mesangial proliferation was ameliorated at
day 7. Tunicamycin and thapsigargin pretreatment amelio-
rated increases in glomerular size and glomerular cell
number, and was associated with a decrease in proteinuria.
It should be noted that there was no improvement in disease
manifestations when tunicamycin was injected after induc-
tion of anti-Thy 1 nephritis.
The molecular mechanisms by which ER stress is evoked
in anti-Thy1 nephritis remain to be elucidated. One proposed
explanation is that the mesangial injury initiated by
complement activation may induce ER stress in mesangial
cells as it does in podocytes. Other mechanisms may also be
relevant to this and other forms of proliferative nephritis.
Recently, production of cytokines, nitric oxide, and reactive
oxygen species has been reported to trigger ER stress.5,24
There is evidence for crosstalk between ER stress and
oxidative stress.5 Moreover, there appears to be a link
between ER stress and nuclear factor (NF)-kB, a key
transcription factor, whose activation induces coordinated
expression of inflammation-associated genes encoding cyto-
kines, chemokines, adhesion receptors, and so on.5,24 Various
chemical inducers of ER stress can activate NF-kB. Activation
may involve ATF6, IRE1, or PERK, as well as the protein
kinase, Akt, changes in cytosolic calcium concentration, and
generation of reactive oxygen species.5,24 Alternatively, there
is evidence that chronic ER stress may decrease NF-kB
activation by inflammatory stimuli.24,25 Mechanisms may
include induction of IkB, C/EBP family transcription factors,
the zinc-finger protein, A20, and others. Thus, although ER
stress may activate NF-kB in the early phase, more chronic
ER stress potentially inhibits NF-kB activation.
EXPRESSION OF ER STRESS MARKERS IN HUMAN KIDNEY
BIOPSIES
Several studies have demonstrated increased expression of ER
stress proteins in human kidney biopsies. An increase in BiP
expression was seen in proteinuric nephropathies, including
FSGS and membranous nephropathy26,27 consistent with
findings in experimental animal models. Minimal change
disease, FSGS, and membranous nephropathy were asso-
ciated with increased expression of the proapoptotic protein,
CHOP.26 Biopsies from patients with membranoproliferative
glomerulonephritis and rapidly progressive glomerulone-
phritis showed upregulation of BiP and CHOP.27 The
presence of CHOP suggests that in at least some glomerular
diseases, the ER stress response has become proapoptotic,
although it should also be noted that CHOP may be
upregulated through nonER stress pathways.
TUBULAR EFFECTS OF PROTEINURIA AND THE ROLE
OF ER STRESS
Proteinuria in glomerular disease has been postulated to
contribute to progressive tubulointerstitial fibrosis, and
excessive urinary protein may represent a direct stress to
renal tubular epithelial cells. In a cell culture model of
proteinuria, it was demonstrated that exposure of tubular
epithelial cells to albumin can lead to activation of
profibrogenic mechanisms and to tubular cell injury.28 In
proximal tubular cells, albumin induced an increase in BiP
and ORP150 expression, as well as apoptosis. Furthermore,
these two ER chaperones were upregulated in proximal
tubular cells in proteinuric PAN (at 3 weeks), and there was
an associated increase in apoptosis.28 In another study,
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protein overload was induced in mice in which BiP was
mutated to remove its ER retention sequence15 (discussed
above). After administration of bovine serum albumin to
these mice, the heterozygous BiP mutant mice developed
severe tubulointerstitial injury, compared with normal mice,
despite similar levels of urinary protein excretion. There was
associated tubular activation of the proapoptotic, caspase-12,
and apoptosis. In experimental type I diabetes induced by
streptozotocin (in rats), BiP and CHOP were upregulated in
whole kidney homogenates after 4 months of diabetes. This
upregulation was associated with an increase in tubular cell
apoptosis.29 Together, these studies support the view that a
tubulointerstitial ER stress response occurs due to an increase
in filtered proteins, and that the ER stress may be
proapoptotic.
To test the hypothesis that proteinuria may induce ER
stress in kidney tubular cells in humans, gene expression was
analyzed in the tubulointerstitial compartment of renal
biopsies of patients with established, proteinuric diabetic
nephropathy.30 For comparison, biopsies with mild diabetic
nephropathy and minimal change disease were analyzed, and
pretransplantation kidney biopsies served as controls. By
microarray analysis, patients with established, but not mild,
diabetic nephropathy showed significant increases in tubular
mRNA levels of genes involved in the UPR (i.e., BiP, ORP150,
XBP1, calnexin, and site-1 protease). In contrast, the mRNA
levels of UPR-induced apoptosis mediators, such as CHOP
and GADD34, were reduced or undetectable in biopsies from
established diabetic nephropathy, compared with the mild
form. The results were confirmed in an independent cohort
of diabetic biopsies, using quantitative reverse transcriptase-
polymerase chain reaction. Moreover, it was shown by
immunofluorescence microscopy that BiP and ORP150
proteins were increased in tubular epithelia. Less pronounced
increases in some ER stress proteins were observed in
tubulointerstitial compartment in minimal change disease.
The authors confirmed that the exposure of cultured renal
tubular epithelial cells to albumin and high glucose enhanced
expression of BiP, ORP150, and XBP1. Thus, the authors
proposed that a protective UPR is induced in proteinuric
diabetic nephropathy.
ROLE OF THE ER AND ER STRESS IN THE PROCESSING OF SLIT
DIAPHRAGM COMPONENTS
Congenital nephrotic syndrome of the Finnish type is an
autosomal recessive disorder, which presents with massive
proteinuria, already evident in utero. The gene responsible,
NPHS1, encodes a podocyte-specific membrane protein,
nephrin, the principal component of the slit diaphragm.31
Normally, nephrin is glycosylated and folded in the ER, and
transported to the plasma membrane. At least 60 distinct
mutations of nephrin have been identified in patients with
congenital nephrotic syndrome, the most common being
missense mutations resulting in single amino-acid substitu-
tions. Transfection of cells with nephrin cDNAs containing
missense mutations showed that a significant number of
these proteins accumulated in the ER, and were not
transported to the cell surface.32 Presumably, the mutations
result in nephrin misfolding, leading to retention in the ER
and ERAD. Sodium 4-phenylbutyrate has been previously
shown to function as a chemical chaperone that can correct
cellular trafficking of several misfolded mutant plasma
membrane proteins, including cystic fibrosis transmembrane
conductance regulator and a1-antitrypsin. Treatment of cells
expressing some of the nephrin missense mutant proteins
with sodium 4-phenylbutyrate resulted in their transport to
the plasma membrane, where they functioned indistinguish-
ably from wild-type nephrin.33 Thus, these nephrin missense
mutants escaped ERAD.
Glucose starvation of nephrin-transfected HEK-293 cells
resulted in an underglycosylated nephrin that remained in
the ER (was not exported to the plasma membrane), and was
associated with an increase in BiP expression.34 The under-
glycosylated nephrin could be recovered in complexes with
calreticulin and calnexin, and to a lesser extent with BiP.
Interestingly, treatment of glucose-deprived cells with
dexamethasone partially rescued nephrin glycosylation and
trafficking, probably through upregulation of genes involved
in adenosine triphosphate production and restoration of
cellular adenosine triphosphate levels. These results imply
that calnexin and calreticulin are involved in nephrin folding
in the ER,7 and the authors suggested that dexamethasone
can improve the chaperoning function of calnexin/calreticu-
lin. Treatment of the nephrin-transfected HEK-293 cells
with a calcium ionophore also increased BiP expression
and underglycosylated forms of nephrin. However, in this
context, dexamethasone did not result in recovery of nephrin
glycosylation. Further investigation is required to determine
whether nephrin underglycosylation is a consequence of ER
stress versus glucose deprivation. In another study, it was
demonstrated that mizoribine, a purine nucleotide biosynth-
esis inhibitor with immunosuppressant properties, improved
the abnormal processing and localization of nephrin induced
by ER stress in cultured cells.20
Mutations in the NPHS2 gene encoding podocin are
associated with an autosomal recessive type of FSGS and
nephrotic syndrome. The R138Q mutation of podocin is a
common missense mutation. Although wild-type podocin
is localized at the plasma membrane, the R138Q mutant
podocin was completely retained intracellularly and coloca-
lized with the ER marker, calnexin.35 The result suggests that
the R138Q mutation affects podocin protein folding. Several
other podocin mutations associated with FSGS also resulted
in ER retention of podocin.36 Treatment of cells with the
chemical chaperones, glycerol, trimethylamine-N-oxide, and
dimethylsulfoxide induced redistribution of R138Q podocin
to the plasma membrane, although restoration of the
function of the protein was not confirmed.35
It has also been proposed that nephrin translation is
facilitated during ER stress.17 Phosphorylation of eIF2a by
PERK leads to a general reduction in protein translation
during ER stress; however, translation of a green fluorescent
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protein-reporter regulated by the 50-end of mouse nephrin
mRNA was paradoxically maintained. This effect was most
likely due to the presence of short open reading frames in this
50-flanking mRNA segment, and is in keeping with the
observations that translation of mRNAs containing short
open reading frames is more efficient after phosphorylation
of eIF2a by PERK.3
PERSPECTIVES
A number of studies appearing in recent years have
demonstrated an association of ER stress with glomerular
diseases. A subset of these studies has also demonstrated a
functional role for ER stress in disease pathogenesis, and
identified previously unrecognized mechanisms. Although
the results are intriguing, a better understanding of the
various aspects of ER stress will be required for the
development of potential therapeutic strategies. There are,
however, some obstacles. Experimental models of acquired
glomerular disease, particularly models involving podocyte
injury or complement activation tend to be more effective in
rats, compared with mice, which generally precludes the use
of genetic manipulation technology. Moreover, deletion of
ER stress genes in mice is frequently lethal, or is associated
with abnormal phenotypes.
In experimental models of membranous nephropathy and
membranoproliferative glomerulonephritis, ER stress pre-
conditioning reduced proteinuria and renal injury. Although
the compounds used for preconditioning may be indepen-
dently cytotoxic, these results provide a rationale for
developing nontoxic methods to induce the activation of
UPR pathways in vivo, and such efforts are underway.37 The
preconditioning studies imply that upregulation of ER
chaperone expression is protective, but it is unknown if such
maneuvers would be useful in the treatment of chronic
phases of such diseases. A better understanding of the
crosstalk and specificity of the UPR pathways is essential. As
discussed above, activation of the UPR pathways may be
protective, but could also be cytotoxic. These differences may
be, in part, related to the specificity of the pathway activated,
and/or to the strength of the activating signal. For example,
modest-to-moderate activation may be beneficial, although
too much activation may be counterproductive.
In glomerular diseases featuring mutations of nephrin or
podocin, with consequent protein misfolding, chemical
chaperones were on occasion effective in correcting abnormal
protein folding and localization. Such studies should
encourage the development of specific small molecule
pharmacological chaperones. Another area that requires
further investigation in these diseases is whether abnormal
proteins activate the UPR, including the upregulation of the
mediators of ERAD. Instead of activation, suppression of the
UPR or ERAD might be beneficial to rescue the function of
mutant proteins and retard disease progression. Abnormal-
ities in the folding of slit diaphragm proteins, such as
nephrin, may also occur in acquired proteinuric renal
diseases. Thus, selective activation of protective aspects of
the UPR (e.g., chaperones), but not of other pathways (e.g.,
ERAD) may be advantageous. Finally, there is increasing
recognition that ER stress may be coupled with other cellular
processes, such as oxidative stress, inflammation, and
autophagy.5,24,38 These associations introduce more complex-
ity, but they also provide additional opportunities for novel
therapeutic approaches.
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